C
Catalyst Biosciences Inc
F:HGF2
Catalyst Biosciences Inc
F:HGF2
Price:
7.404
EUR
1 377.84%
Market Closed
Market Cap:
€279.6m
Cash Flow Statement
Cash Flow Statement
Catalyst Biosciences Inc
Catalyst Biosciences Inc
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
(56)
|
(88)
|
(8)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
|
| Other Non-Cash Items |
4
|
3
|
(20)
|
|
| Change in Working Capital |
(3)
|
0
|
(5)
|
|
| Cash from Operating Activities |
(55)
N/A
|
(84)
-52%
|
(33)
+60%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
(0)
|
(1)
|
0
|
|
| Other Items |
10
|
49
|
55
|
|
| Cash from Investing Activities |
10
N/A
|
48
+399%
|
55
+15%
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
60
|
50
|
0
|
|
| Cash Paid for Dividends |
0
|
0
|
(45)
|
|
| Cash from Financing Activities |
60
N/A
|
50
-18%
|
(45)
N/A
|
|
| Change in Cash | ||||
| Net Change in Cash |
15
N/A
|
14
-7%
|
(23)
N/A
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
(55)
N/A
|
(85)
-53%
|
(33)
+61%
|
|
Switch to:
Switch to:
See Also
Discover More
